Live Breaking News & Updates on Jacques Bouchyevp Investor Relations Business Development|Page 2

Stay updated with breaking news from Jacques bouchyevp investor relations business development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kineta Announces Participation at October Investor Conferences

Kineta Announces Participation at October Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Group Family Office Private Wealth Management Forum , Kineta Inc , John Mullalylifesci Advisors , Jacques Bouchyevp Investor Relations Business Development , Summit Format , Family Office , Private Wealth Management Forum West , Business Development ,

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Jacques Bouchyevp Investor Relations Business Development , Hc Wainwright Co , Kineta Inc , John Mullalylifesci Advisors , Company Or Kineta , Exchange Commission , Securities Act , Statements Regarding Forward Looking , Private Securities Litigation Reform Act , Annual Report ,

Kineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023

Kineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Thierry Guillaudeux , Kineta Inc , Jacques Bouchyevp Investor Relations Business Development , Exchange Commission , John Mullalylifesci Advisors , American Association For Cancer Research , American Association , Cancer Research , Annual Meeting , Chief Scientific Officer , Therapeutic Benefit , Poster Title , Abstract Number , Private Securities Litigation Reform Act , Annual Report , Business Development ,